share_log

塩野義薬---大幅反落、肥満症治療薬のフェーズ2試験結果を嫌気

Shionogi - significant decline, phase 2 trial results of obesity treatment drugs met with strong disapproval.

Fisco Japan ·  Jun 6 20:57

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment